Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder.

Levin, Edward D., Conners, C. Keith, Silva, Donna, Canu, Will, March, John·2001·Experimental and Clinical Psychopharmacology

Abstract

Acute nicotine treatment has been found to reduce symptoms of attention deficit/hyperactivity disorder in adults (E. D. Levin, C. K. Conners, et al., 1996). In this study, chronic nicotine effects were compared with placebo and methylphenidate. Acute and chronic nicotine treatment significantly attenuated the rise in hit reaction time standard error over session blocks on the Conners Continuous Performance Test (C. K. Conners et al., 1996). Acute nicotine significantly reduced severity of clinical symptoms on the Clinical Global Impressions scale (National Institute of Mental Health, 1985). Nicotine caused a significant decrease in self-report of depressive mood as measured by the Profile of Mood States test (D. M. McNair, M. Lorr, & L. F. Droppleman, 1981). This small study (40 participants) provided evidence that nicotine treatment can reduce severity of attentional deficit symptoms and produce improvement on an objective computerized attention task.

Cites (2)

  1. A Pilot Controlled Clinical Trial of ABT-418, a Cholinergic Agonist, in the Treatment of Adults With Attention Deficit Hyperactivity Disorder
    Wilens, Timothy E., Biederman, Joseph, Spencer, Thomas J., Bostic, Jeff, Prince, Jefferson, Monuteaux, Michael C., Soriano, Jennifer, Fine, Catherine, Abrams, Annah, Rater, Michael et al. · 1999 · American Journal of Psychiatry
  2. Sustained release and standard methylphenidate effects on cognitive and social behavior in children with attention deficit disorder
    Pelham, William E., Sturges, James, Hoza, JoAnn, Schmidt, Casey, Bijlsma, Jan Jaap, Milich, Richard, Moorer, Sam · 1987 · PEDIATRICS

Show all 2 references

Cited by (21)

  1. Reliability and validity of a computerized neurocognitive test battery, CNS vital signs
    GUALTIERI, C, JOHNSON, L · 2006 · Archives of Clinical Neuropsychology
  2. Guidelines on nicotine dose selection for in vivo research
    Matta, Shannon G., Balfour, David J., Benowitz, Neal L., Boyd, R. Thomas, Buccafusco, Jerry J., Caggiula, Anthony R., Craig, Caroline R., Collins, Allan C., Damaj, M. Imad, Donny, Eric C. et al. · 2007 · Psychopharmacology
  3. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization
    Levin, Edward D., McClernon, F. Joseph, Rezvani, Amir H. · 2006 · Psychopharmacology
  4. Nicotinic acetylcholine receptors: From basic science to therapeutics
    Hurst, Raymond, Rollema, Hans, Bertrand, Daniel · 2013 · Pharmacology & Therapeutics
  5. A Comparison of the Efficacy of Medications for Adult Attention-Deficit/Hyperactivity Disorder Using Meta-Analysis of Effect Sizes
    Faraone, Stephen V., Glatt, Stephen J. · 2010 · The Journal of Clinical Psychiatry

See all 168

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder. https://app.cochat.ai/papers/10.1037//1064-1297.9.1.83
The paper
Levin, E. D., Conners, C. K., Silva, D., Canu, W., & March, J. (2001). Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder. Experimental and Clinical Psychopharmacology. https://doi.org/10.1037//1064-1297.9.1.83

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.